Supplementary Figures 1-5 from Equilibrium Between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma

Bin Zhang,Yi Zhang,Natalie A. Bowerman,Andrea Schietinger,Yang-Xin Fu,David M. Kranz,Donald A. Rowley,Hans Schreiber

DOI: https://doi.org/10.1158/0008-5472.22374525.v1

2023-01-01

Abstract:Supplementary Figures 1-5 from Equilibrium between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma

What problem does this paper attempt to address?

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Wenqun Zhong,Zebin Xiao,Zhiyuan Qin,Jingbo Yang,Yi Wen,Ziyan Yu,Yumei Li,Neil C. Sheppard,Serge Y. Fuchs,Xiaowei Xu,Meenhard Herlyn,Carl H. June,Ellen Puré,Wei Guo

DOI: https://doi.org/10.1158/0008-5472.23907869

2023-01-01

Abstract:Supplementary Figures and Figure Legends
Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Xiaohui Fan,Randall J. Brezski,Hui Deng,Pooja Dhupkar,Yun Q. Shi,Anneliese Gonzalez,Songlin Zhang,Michael A. Rycyzyn,William R. Strohl,Robert E. Jordan,Ningyan Zhang,Zhiqiang An

DOI: https://doi.org/10.1158/1535-7163.22501711

2023-01-01

Abstract:Figure S1: IdeS expression in BT474 breast cancer cells Figure S2: Detection of MMPs in cancer cell lysates and culture supernatant Figure S3: scIgG-T was not in the SKBR-3 cell culture medium Figure S4: Detection of immune cells infiltration in mice by flow cytometry.
Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Jiahui Mou,Meijun Huang,Feifei Wang,Xiaoding Xu,Hanqi Xie,Henglei Lu,Mingyang Li,Yu Li,Weiwen Kong,Jing Chen,Ying Xiao,Yiding Chen,Chaochen Wang,Jin Ren

DOI: https://doi.org/10.1158/1541-7786.22527890

2023-01-01

Abstract:Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis
Supplementary Figure from Comprehensive Characterizations of Immune Receptor Repertoire in Tumors and Cancer Immunotherapy Studies

Li Song,Zhangyi Ouyang,David Cohen,Yang Cao,Jennifer Altreuter,Gali Bai,Xihao Hu,Kenneth J. Livak,Heng Li,Ming Tang,Bo Li,X. Shirley Liu

DOI: https://doi.org/10.1158/2326-6066.22544670.v1

2023-01-01

Abstract:Supplementary Figure from Comprehensive Characterizations of Immune Receptor Repertoire in Tumors and Cancer Immunotherapy Studies
Supplementary Figure S1 from B7 Blockade Alters the Balance Between Regulatory T Cells and Tumor-reactive T Cells for Immunotherapy of Cancer

Penghui Zhou,Xincheng Zheng,Huiming Zhang,Yang Liu,Pan Zheng

DOI: https://doi.org/10.1158/1078-0432.22440672.v1

2023-01-01

Abstract:Supplementary Figure S1 from B7 Blockade Alters the Balance between Regulatory T Cells and Tumor-reactive T Cells for Immunotherapy of Cancer
Supplementary Figure 5 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Sid P. Kerkar,Pawel Muranski,Andrew Kaiser,Andrea Boni,Luis Sanchez-Perez,Zhiya Yu,Douglas C. Palmer,Robert N. Reger,Zachary A. Borman,Ling Zhang,Richard A. Morgan,Luca Gattinoni,Steven A. Rosenberg,Giorgio Trinchieri,Nicholas P. Restifo

DOI: https://doi.org/10.1158/0008-5472.22384254

2023-01-01

Abstract:Supplementary Figure 5 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Supplementary Figure 4 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Sid P. Kerkar,Pawel Muranski,Andrew Kaiser,Andrea Boni,Luis Sanchez-Perez,Zhiya Yu,Douglas C. Palmer,Robert N. Reger,Zachary A. Borman,Ling Zhang,Richard A. Morgan,Luca Gattinoni,Steven A. Rosenberg,Giorgio Trinchieri,Nicholas P. Restifo

DOI: https://doi.org/10.1158/0008-5472.22384257

2023-01-01

Abstract:Supplementary Figure 4 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Supplementary Figure 3 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Sid P. Kerkar,Pawel Muranski,Andrew Kaiser,Andrea Boni,Luis Sanchez-Perez,Zhiya Yu,Douglas C. Palmer,Robert N. Reger,Zachary A. Borman,Ling Zhang,Richard A. Morgan,Luca Gattinoni,Steven A. Rosenberg,Giorgio Trinchieri,Nicholas P. Restifo

DOI: https://doi.org/10.1158/0008-5472.22384260.v1

2023-01-01

Abstract:Supplementary Figure 3 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Supplementary Figure 6 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Sid P. Kerkar,Pawel Muranski,Andrew Kaiser,Andrea Boni,Luis Sanchez-Perez,Zhiya Yu,Douglas C. Palmer,Robert N. Reger,Zachary A. Borman,Ling Zhang,Richard A. Morgan,Luca Gattinoni,Steven A. Rosenberg,Giorgio Trinchieri,Nicholas P. Restifo

DOI: https://doi.org/10.1158/0008-5472.22384251

2023-01-01

Abstract:Supplementary Figure 6 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Supplementary Figures 1-3 from Cytochrome P450 Epoxygenase Promotes Human Cancer Metastasis

Jian-Gang Jiang,Yao-Gui Ning,Chen Chen,Ding Ma,Zhen-Jun Liu,Shilin Yang,Jianfeng Zhou,Xiao Xiao,Xin A. Zhang,Matthew L. Edin,Jeffrey W. Card,Jianing Wang,Darryl C. Zeldin,Dao Wen Wang

DOI: https://doi.org/10.1158/0008-5472.22367933.v1

2023-01-01

Abstract:Supplementary Figures 1-3 from Cytochrome P450 Epoxygenase Promotes Human Cancer Metastasis
Supplementary Figure 1 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Sid P. Kerkar,Pawel Muranski,Andrew Kaiser,Andrea Boni,Luis Sanchez-Perez,Zhiya Yu,Douglas C. Palmer,Robert N. Reger,Zachary A. Borman,Ling Zhang,Richard A. Morgan,Luca Gattinoni,Steven A. Rosenberg,Giorgio Trinchieri,Nicholas P. Restifo

DOI: https://doi.org/10.1158/0008-5472.22384266

2023-01-01

Abstract:Supplementary Figure 1 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Supplementary Figure 2 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Sid P. Kerkar,Pawel Muranski,Andrew Kaiser,Andrea Boni,Luis Sanchez-Perez,Zhiya Yu,Douglas C. Palmer,Robert N. Reger,Zachary A. Borman,Ling Zhang,Richard A. Morgan,Luca Gattinoni,Steven A. Rosenberg,Giorgio Trinchieri,Nicholas P. Restifo

DOI: https://doi.org/10.1158/0008-5472.22384263

2023-01-01

Abstract:Supplementary Figure 2 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Supplementary Figure 7 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Sid P. Kerkar,Pawel Muranski,Andrew Kaiser,Andrea Boni,Luis Sanchez-Perez,Zhiya Yu,Douglas C. Palmer,Robert N. Reger,Zachary A. Borman,Ling Zhang,Richard A. Morgan,Luca Gattinoni,Steven A. Rosenberg,Giorgio Trinchieri,Nicholas P. Restifo

DOI: https://doi.org/10.1158/0008-5472.22384248

2023-01-01

Abstract:Supplementary Figure 7 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Supplementary Text from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Bin Wang,Qiang Wang,Zhe Wang,Jun Jiang,Shi-Cang Yu,Yi-Fang Ping,Jing Yang,Sen-Lin Xu,Xian-Zong Ye,Chuan Xu,Lang Yang,Cheng Qian,Ji Ming Wang,You-Hong Cui,Xia Zhang,Xiu-Wu Bian

DOI: https://doi.org/10.1158/0008-5472.22401479.v1

2023-01-01

Abstract:Supplementary Text including Supplementary Methods and Supplementary Figure Legends
Supplementary Figure 2 from Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

Jun Zhao,Mark Z. Ma,Hening Ren,Zhenqiu Liu,Martin J. Edelman,Hong Pan,Li Mao

DOI: https://doi.org/10.1158/1078-0432.22452492.v1

2023-01-01

Abstract:Supplementary Figure 2 - PDF file 693K, Notch intracellular domain IHC
Supplementary Data from Efficient Tumor Clearance and Diversified Immunity Through Neoepitope Vaccines and Combinatorial Immunotherapy

Karin L. Lee,Stephen C. Benz,Kristin C. Hicks,Andrew Nguyen,Sofia R. Gameiro,Claudia Palena,J. Zachary Sanborn,Zhen Su,Peter Ordentlich,Lars Rohlin,John H. Lee,Shahrooz Rabizadeh,Patrick Soon‐Shiong,Kayvan Niazi,Jeffrey Schlom,Duane H. Hamilton

DOI: https://doi.org/10.1158/2326-6066.22542444

2023-01-01

Abstract:Supplementary figures and tables
Supplemental Data from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Jing Huang,Lin Xiao,Xiaoting Gong,Wenwei Shao,Yanhui Yin,Qinyuan Liao,Yang Meng,Yingmei Zhang,Dalong Ma,Xiaoyan Qiu

DOI: https://doi.org/10.1158/0008-5472.22402070.v1

2023-01-01

Abstract:Supplemental materials and methods and legends for all supplemental figures.
Supplementary Figures 1-6 from Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands

Rosa Conforti,Yuting Ma,Yannis Morel,Carine Paturel,Magali Terme,Sophie Viaud,Bernard Ryffel,Maria Ferrantini,Ravindra Uppaluri,Robert Schreiber,Christophe Combadière,Nathalie Chaput,Fabrice André,Guido Kroemer,Laurence Zitvogel

DOI: https://doi.org/10.1158/0008-5472.22383845

2023-01-01

Abstract:Supplementary Figures 1-6 from Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands
Supplementary Figures and Tables from an IL6–Adenosine Positive Feedback Loop Between CD73+ Γδtregs and CAFs Promotes Tumor Progression in Human Breast Cancer

Guoming Hu,Pu Cheng,Jun Pan,Shimin Wang,Qingqing Ding,Jing Zhou,Cheng Liu,Xuan Shao,Liming Huang,Jikun Huang

DOI: https://doi.org/10.1158/2326-6066.22542160.v1

2023-01-01

Abstract:Supplemental Figures 1-12 and Supplementary Tables 1-3

Supplementary Figures 1-5 from Equilibrium Between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Figure from Comprehensive Characterizations of Immune Receptor Repertoire in Tumors and Cancer Immunotherapy Studies

Supplementary Figure S1 from B7 Blockade Alters the Balance Between Regulatory T Cells and Tumor-reactive T Cells for Immunotherapy of Cancer

Supplementary Figure 5 from Tumor-Specific CD8<sup>+</sup> T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 4 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 3 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 6 from Tumor-Specific CD8<sup>+</sup> T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figures 1-3 from Cytochrome <i>P</i>450 Epoxygenase Promotes Human Cancer Metastasis

Supplementary Figure 1 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 2 from Tumor-Specific CD8<sup>+</sup> T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 7 from Tumor-Specific CD8<sup>+</sup> T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Text from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Supplementary Figure 2 from Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

Supplementary Data from Efficient Tumor Clearance and Diversified Immunity Through Neoepitope Vaccines and Combinatorial Immunotherapy

Supplemental Data from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Supplementary Figures 1-6 from Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands

Supplementary Figures and Tables from an IL6–Adenosine Positive Feedback Loop Between CD73<sup>+</sup> Γδtregs and CAFs Promotes Tumor Progression in Human Breast Cancer

Supplementary Figures 1-5 from Equilibrium Between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Figure from Comprehensive Characterizations of Immune Receptor Repertoire in Tumors and Cancer Immunotherapy Studies

Supplementary Figure S1 from B7 Blockade Alters the Balance Between Regulatory T Cells and Tumor-reactive T Cells for Immunotherapy of Cancer

Supplementary Figure 5 from Tumor-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 4 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 3 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 6 from Tumor-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figures 1-3 from Cytochrome &lt;i&gt;P&lt;/i&gt;450 Epoxygenase Promotes Human Cancer Metastasis

Supplementary Figure 1 from Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 2 from Tumor-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 7 from Tumor-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Text from Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells

Supplementary Figure 2 from Anti-HDGF Targets Cancer and Cancer Stromal Stem Cells Resistant to Chemotherapy

Supplementary Data from Efficient Tumor Clearance and Diversified Immunity Through Neoepitope Vaccines and Combinatorial Immunotherapy

Supplemental Data from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Supplementary Figures 1-6 from Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands

Supplementary Figures and Tables from an IL6–Adenosine Positive Feedback Loop Between CD73&lt;sup&gt;+&lt;/sup&gt; Γδtregs and CAFs Promotes Tumor Progression in Human Breast Cancer

Supplementary Figure 5 from Tumor-Specific CD8<sup>+</sup> T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 6 from Tumor-Specific CD8<sup>+</sup> T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figures 1-3 from Cytochrome <i>P</i>450 Epoxygenase Promotes Human Cancer Metastasis

Supplementary Figure 2 from Tumor-Specific CD8<sup>+</sup> T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figure 7 from Tumor-Specific CD8<sup>+</sup> T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts

Supplementary Figures and Tables from an IL6–Adenosine Positive Feedback Loop Between CD73<sup>+</sup> Γδtregs and CAFs Promotes Tumor Progression in Human Breast Cancer